Company Search:
Advanced Search
Sponsored Links
Clovis Oncology Inc Company Snapshot
Clovis Oncology Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Clovis Oncology Inc with three other companies in this sector in UNITED STATES : Insmed Incorporated (2019 sales of $136.47 million of which 100% was Pharmaceutical Products), Heron Therapeutics Inc ($145.97 million of which 100% was Polymer Technologies), and Esperion Therapeutics, Inc. ($148.36 million of which 100% was Pharmaceuticals Pro).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Clovis Oncology Inc
  Stock Performance Chart for Clovis Oncology Inc
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 5.42
(Figures in U.S. Dollars)
1 Week -6.4%   13 Weeks -18.1%  
4 Weeks -39.9%   52 Weeks -4.6%  
Clovis Oncology Inc Key Data:
  Ticker: CLVS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 143,006,000
(Year Ending Jan 2020).
Employees: 484
  Currency: U.S. Dollars Market Cap: 478,026,141
  Fiscal Yr Ends: December Shares Outstanding: 88,196,705
  Share Type: Common Closely Held Shares: 1,780,403
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.